000 01239 a2200325 4500
005 20250517213500.0
264 0 _c20190923
008 201909s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/acs.jmedchem.7b01686
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJoharapurkar, Amit A
245 0 0 _aProlyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_c08 2018
300 _a6964-6982 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aGenetic Diseases, Inborn
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProlyl-Hydroxylase Inhibitors
_xchemistry
650 0 4 _aRenal Insufficiency, Chronic
_xdrug therapy
700 1 _aPandya, Vrajesh B
700 1 _aPatel, Vishal J
700 1 _aDesai, Ranjit C
700 1 _aJain, Mukul R
773 0 _tJournal of medicinal chemistry
_gvol. 61
_gno. 16
_gp. 6964-6982
856 4 0 _uhttps://doi.org/10.1021/acs.jmedchem.7b01686
_zAvailable from publisher's website
999 _c28343358
_d28343358